Honeywell (HON)

Jim Cramer at The Cable Show
s_bukley/Shutterstock

“At this point in the business cycle, the playbook says you have to go with more tangible companies that make real things and generate real profits,” Cramer said last week on CNBC.

One company he feels fits that bill is Fortune 100 mainstay Honeywell. (The company was ranked 94 in 2021.)

As a global industrial conglomerate, Honeywell provides an attractively diversified mix of services and products that range from aerospace and building technologies to safety and productivity solutions.

Despite a snarled global supply chain and decreased demand from its deep-pocketed airline customers, Q3 2021 saw Honeywell increase sales by 8% year over year. Earnings per share increased by 29% over the same period.

Bausch Health Companies (BHC)

Bausch Health company logo icon on tablet screen close-up. Bausch Health brand
Kate Krav-Rude/Shutterstock

Bausch Health is a Canadian pharmaceutical company that develops, manufactures and markets pharma products and branded generic drugs that target a wide variety of health disorders.

Pharma and healthcare companies are always intriguing plays during times of high inflation, as their products remain in demand even if prices rise.

Cramer, however, is most excited by the fact that Bausch plans on breaking itself into three separate entities: eye health, medical aesthetics and pharmaceuticals.

“I like a big breakup story,” he said during a recent episode of Halftime Report. “Among planned splits at Johnson & Johnson, General Electric and Bausch, I like Bausch Health as the best breakup.”

Bausch’s stock has risen just under 15% in the past 12 months.

Chevron (CVX)

Chevron logo sign with blue sky background
Sasima/Shutterstock

Chevron is looking pretty good.

America’s second largest oil company continues to benefit from the ongoing inflation-driven rally in energy prices. But it also plans on investing a gargantuan sum of money into its renewable natural gas and hydrogen businesses — $10 billion by 2028 — that should keep the company relevant for decades to come.

Chevron had an absolutely mouth-watering Q3 last year: $6.1 billion in earnings, $5.6 billion in debt reduction and $2.6 billion in dividends paid out to investors.

The company’s stock is up over 30% in just the last four months. It could go even higher.

“I like Chevron because I just think that oil is still undervalued even after last year,” Cramer said.

Eli Lilly (LLY)

Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals V
Jonathan Weiss/Shutterstock

The sale of COVID antibody-based treatments will help pharma giant Eli Lilly make a projected $28 billion in sales for 2021, but the company is also making progress with its experimental Alzheimer’s drug, donanemab.

In June, the Food and Drug Administration designated donanemab a “breakthrough therapy” based on preliminary clinical evidence. That means the FDA will expedite the drug’s review. A decision regarding the drug’s approval is expected in the second half of 2022. “This one works,” Cramer said.

A bet on Eli Lilly isn’t simply a speculative play based on new drugs. The company’s stock is up more than 215% over the last five years — a very lucrative pickup, especially if you had invested using free investment apps.

More from MoneyWise

About the Author

Brian Pacampara, CFA

Brian Pacampara, CFA

Investing Editor

Brian is an editor for MoneyWise. A long-time stock junkie, his work has appeared in The Motley Fool, Seeking Alpha, and Yahoo Finance. He believes in owning "Forever Stocks" — a rare group of businesses that have paid out dividends for decades. Brian holds the Chartered Financial Analyst (CFA) designation.

You May Also Like

4 Ways to Earn Big Returns in 2022 Without the Shaky Stock Market

Don't limit yourself to the stock market. These alternatives can trounce the S&P 500.

4 Alternative Ways to Diversify Your Portfolio as an Accredited Investor

Bolster your portfolio against stock market volatility.

Want to Earn Big Returns Without the Shaky Stock Market? Try Art

Art investment is no longer reserved for the wealthy

Do Big Stores Save You the Most? We Price-Check Our Shopping List

With one 30-second trick, we found $460 in savings beyond Walmart and Amazon.